LMGAM
VRTX icon

Liberty Mutual Group Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Liberty Mutual Group Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-10,186
Closed -$1.96M – 767
2018
Q3 		$1.96M Hold
10,186
– – 0.04% 156
2018
Q2 		$1.73M Buy
10,186
+138
+1% +$21.4K 0.04% 174
2018
Q1 		$1.64M Hold
10,048
– – 0.05% 192
2017
Q4 		$1.51M Sell
10,048
-38
-0.4% -$5.63K 0.04% 258
2017
Q3 		$1.53M Sell
10,086
-5,572
-36% -$839K 0.08% 255
2017
Q2 		$2.02M Buy
15,658
+2,656
+20% +$320K 0.08% 302
2017
Q1 		$1.42M Sell
13,002
-5,097
-28% -$449K 0.06% 500
2016
Q4 		$1.33M Buy
18,099
+387
+2% +$31.5K 0.05% 562
2016
Q3 		$1.54M Buy
17,712
+634
+4% +$59.9K 0.05% 436
2016
Q2 		$1.47M Buy
17,078
+1,102
+7% +$95.2K 0.05% 451
2016
Q1 		$1.27M Buy
15,976
+1,609
+11% +$146K 0.05% 481
2015
Q4 		$1.81M Sell
14,367
-1,253
-8% -$151K 0.07% 409
2015
Q3 		$1.63M Sell
15,620
-1,170
-7% -$150K 0.06% 496
2015
Q2 		$2.07M Sell
16,790
-5,897
-26% -$743K 0.07% 369
2015
Q1 		$2.68M Buy
22,687
+16
+0.1% +$1.92K 0.08% 303
2014
Q4 		$2.69M Sell
22,671
-5,019
-18% -$565K 0.08% 283
2014
Q3 		$3.11M Sell
27,690
-854
-3% -$81.3K 0.1% 218
2014
Q2 		$2.7M Sell
28,544
-327
-1% -$22.9K 0.09% 268
2014
Q1 		$2.04M Buy
28,871
+4,313
+18% +$342K 0.07% 423
2013
Q4 		$1.82M Buy
24,558
+10,501
+75% +$731K 0.06% 384
2013
Q3 		$1.07M Sell
14,057
-77,191
-85% -$6.14M 0.04% 560
2013
Q2 		$7.3M Buy
+91,248
New +$6.72M 0.29% 58

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Liberty Mutual Group Asset Management's VRTX Position: Q4 2018 in Review

Liberty Mutual Group Asset Management sold out of Vertex Pharmaceuticals (VRTX) in Q4 2018, closing a stake of 10,186 shares — an estimated $1.96M sold.

Liberty Mutual Group Asset Management first reported a position in VRTX in Q2 2013 and held it in 22 quarters. The position peaked at $7.3M in Q2 2013. 706 funds tracked by Wall St. Rank hold VRTX as of Q4 2018.

  • Liberty Mutual Group Asset Management reported no remaining Vertex Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Liberty Mutual Group Asset Management sold 10,186 Vertex Pharmaceuticals shares in Q4 2018, an estimated $1.96M.
  • Liberty Mutual Group Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 22 quarters.
  • Liberty Mutual Group Asset Management's Vertex Pharmaceuticals position peaked at $7.3M in Q2 2013.
  • 706 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2018.

Based on Liberty Mutual Group Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.